Injektion von Botulinum Toxin in den Pylorus zur Behandlung von Chronic Upper Gastrointestinal Symptoms bei Diabetic Patients mit verzögerter Gastric Emptying
- Conditions
- Diabetes mellitus
- Registration Number
- EUCTR2004-004217-42-AT
- Lead Sponsor
- AKH Wien
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Diabetic gastroparesis
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
no diabetic gastroparesis
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Treatment of diabetic gastroparesis;Secondary Objective: ;Primary end point(s): 3 months after BTxA injection
- Secondary Outcome Measures
Name Time Method